University Hospital Tübingen (AöR) — Tübingen

Public research footprint of University Hospital Tübingen (AöR), compiled from the ClinicalTrials.gov public registry.

136

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-metastatic Castration-resistant Prostate Cancer · Parkinson Disease · Multiple Myeloma · Biochemical Recurrence of Malignant Neoplasm of Prostate

Recently updated registry entries

NCT07739914 — Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver… (Not Yet Recruiting)
NCT07672236 — A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in… (Recruiting)
NCT05911633 — BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospital Tübingen (AöR)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.